Nuvectis Pharma
NVCT
NVCT
36 hedge funds and large institutions have $12.8M invested in Nuvectis Pharma in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+3
Holders Change %
+9.09%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
16
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$353K |
| 2 |
Millennium Management
New York
|
+$284K |
| 3 |
BlackRock
New York
|
+$237K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$228K |
| 5 |
Renaissance Technologies
New York
|
+$220K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AIG
26
American International Group
New York
| $30.8K | -$133 | -16 | -0.4% |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $19K | +$10.2K | +1,259 | +116% |
|
28
Wells Fargo
San Francisco,
California
| $15.9K | +$3.65K | +437 | +30% |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $10.7K | -$50.1K | -6,004 | -82% |
|
30
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
| $10.2K | -$3.48K | -417 | -25% |
|
31
Citigroup
New York
| $9.24K | +$9.2K | +1,103 | +22,060% |
|
|
AB
32
Amalgamated Bank
New York
| $8K | -$569 | -69 | -7% |
|
33
Legal & General Group
London,
United Kingdom
| $7.01K | – | – | – |
|
|
AIP
34
Ameritas Investment Partners
Lincoln,
Nebraska
| $4.72K | – | – | – |
|
|
HCM
35
Hollencrest Capital Management
Newport Beach,
California
| $2.34K | – | – | – |
|
36
Fidelity Investments
Boston,
Massachusetts
| $17 | -$43 | -5 | -71% |
|
|
MWM
37
Moran Wealth Management
Naples,
Florida
| – | -$215K | -16,697 | Closed |
|
|
DWA
38
Dorsey Wright & Associates
Pasadena,
California
| – | -$18K | -1,396 | Closed |
|